Timmerman Report
The Long Run with Luke Timmerman
"The Long Run"Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join ho...
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Ep79: Daphne Koller on Machine Learning for Drug Discovery 26.10.2020 1:09:32
Daphne Koller, CEO of insitro, on machine learning for drug discovery
Ep78: Pearl Huang on Exoneural Cancer Biology 13.10.2020 1:06:10
Pearl Huang, CEO of Cygnal Therapeutics, on Exoneural Cancer Biology
Ep77: Jennifer Petter on Drugging RNA Targets 29.09.2020 1:21:25
Jennifer Petter, CSO of Arrakis Therapeutics, on small molecule drugs for RNA targets
Ep76: Otello Stampacchia on Becoming a Biotech VC 08.09.2020 1:08:54
Otello Stampacchia on becoming a biotech venture capitalist.
Ep75: Rosana Kapeller on Drugging the Repeatome 10.08.2020 1:03:45
Rosana Kapeller, CEO of ROME Therapeutics
Ep74: Abe Ceesay's Path to Leadership 21.07.2020 1:15:44
Abe Ceesay, CEO of Tiburio Therapeutics
Ep73: Kevin Ness on Digital Genome Engineering 07.07.2020 1:04:56
Ep73: Kevin Ness on Digital Genome Engineering by Timmerman Report
Conversation on Race with Ted Love 13.06.2020 35:25
Ted Love, CEO of Global Blood Therapeutics, on Racial Inequity
Ep71: Andy Plump 10.06.2020 42:02
Takeda R&D president Andy Plump on fighting COVID19 and racism.
Ep70: Nina Kjellson 26.05.2020 1:04:38
Nina Kjellson forging a path in biotech venture capital.
Vaccine Strategy with Larry Corey 14.05.2020 34:49
Ep69 of The Long Run with virologist Larry Corey
Ep68: Emma Hodcroft 30.04.2020 41:29
Emma Hodcroft on NextStrain and viral evolution
Ep67: George Scangos 17.04.2020 36:22
George Scangos of VIR on neutralizing antibodies for SARS-CoV-2
Ep66: Mike Pellini 05.04.2020 38:21
Mike Pellini on COVID19 diagnostic testing.
Ep65: Alexis Borisy & Melanie Nallicheri 24.03.2020 57:51
Leaders of EQRx, a company aspiring to make novel drugs at low prices.
Ep64: Isabella de la Houssaye 09.03.2020 49:25
Isabella is a Stage 4 lung cancer patient on a mission.
Ep63: Jeremy Levin 25.02.2020 59:29
Jeremy Levin, chairman of BIO, on the perilous moment in politics.
Ep62: Jane Grogan 11.02.2020 55:56
Jane Grogan, CSO of Arsenal Bio, on programmable cell therapies.
Ep61: Sanjiv Patel 27.01.2020 1:05:23
Sanjiv Patel, CEO of Relay Therapeutics, computational drug discovery company.
Ep60: Tim Mayleben 14.01.2020 1:09:54
Tim Mayleben, CEO of Esperion Therapeutics, on cholesterol-lowering meds.
Ep59: David Baker 30.12.2019 1:01:31
David Baker, University of Washington protein designer.
Ep58: Jigar Raythatha 03.12.2019 1:11:54
Jigar Raythatha of Constellation Pharma on epigenetic drug development.
Ep57: John Alam 26.11.2019 1:20:30
John Alam on Alzheimer's drug development.
Ep56: Tim Springer 13.11.2019 1:05:03
Tim Springer of Harvard Medical School on his career in science and biotech.
Ep55: John Hawkins & Jim Geraghty 29.10.2019 1:06:33
Discussion on the new Henri Termeer biography.
Similar podcasts
Listen to the The Long Run with Luke Timmerman podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
